Castor expands into post-marketing studies to cut costs, accelerate deployment
Hybrid and decentralized clinical trial specialist Castor is expanding into post-marketing studies with a service intended to reduce costs by 30%.
Headlines
Global Industry News
-
CGT Catapult: Developing and growing UK advanced therapies workforce is key priority
from BioPharma-Reporter.com
-
Fujifilm invests $188m in new North Carolina cell culture media facility
from BioPharma-Reporter.com
-
Long-COVID personalized medicine enters Phase 2 trial
from BioPharma-Reporter.com
-
Blue Water Vaccines to develop oral chlamydia vaccine
from BioPharma-Reporter.com
Hot Topics
-
Survey reveals decentralized clinical trial elements that drive participation in studies
Patient centricity
-
Castor bolsters trial solutions platforms to reach more patients and gain RWE
Clinical evolution
-
Medable launches new tool for global remote consent
Patient centricity
-
Oracle and ObvioHealth come together for ‘tight integration’ of data in APAC DCTs
Globalization
